Study of TLR9 Agonist Vidutolimod (CMP-001) in Combination With Nivolumab vs. Nivolumab
Clinical trial NCT04401995 · COMPLETED
Trial details
- NCT number
- NCT04401995
- Sponsor
- Diwakar Davar
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-02
- Primary completion
- 2024-08-16
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.